Synbiotics for the Management of Cancer
This book illustrates the significance of probiotics and prebiotics for the management of various types of cancers. The up-to-date chapters provide recent information about the effect of anticancer treatment approaches on gut microbiota, the correlation between ROS and synbiotics for effective cance...
Na minha lista:
| Autor Corporativo: | |
|---|---|
| Outros Autores: | , , , , |
| Formato: | Recurso Electrónico livro electrónico |
| Idioma: | inglês |
| Publicado em: |
Singapore :
Springer Nature Singapore : Imprint: Springer,
2023.
|
| Edição: | 1st ed. 2023. |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/978-981-19-7550-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-981-19-7550-9 | ||
| 003 | DE-He213 | ||
| 005 | 20260810115156.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230325s2023 si | o |||| 0|eng d | ||
| 020 | |a 9789811975509 |9 978-981-19-7550-9 | ||
| 024 | 7 | |a 10.1007/978-981-19-7550-9 |2 doi | |
| 050 | 4 | |a RM300-666 | |
| 072 | 7 | |a MMG |2 bicssc | |
| 072 | 7 | |a MED071000 |2 bisacsh | |
| 072 | 7 | |a MKG |2 thema | |
| 082 | 0 | 4 | |a 615 |2 23 |
| 245 | 1 | 0 | |a Synbiotics for the Management of Cancer |h [electronic resource] / |c edited by Neeraj Mishra, Shvetank Bhatt, Keshav Raj Paudel, Philip M Hansbro, Kamal Dua. |
| 250 | |a 1st ed. 2023. | ||
| 264 | 1 | |a Singapore : |b Springer Nature Singapore : |b Imprint: Springer, |c 2023. | |
| 300 | |a 1 online resource (XVII, 340 p. 1 illus.). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Chapter 1_Introduction to Cancer -- Chapter 2_Effect of anticancer treatment approches on gut microbiota -- Chapter 3_Synbiotic: A promising approach for the treatment of cancer -- Chapter 4_Correlation between ROS and Synbiotics for effective treatment of cancer -- Chapter 5_Influence of synbiotics on inflammation and immune microenvironment for the treatment of cancer -- Chapter 6_Synbiotics in colorectal cancer -- Chapter 7_Synbiotics in cervical cancer -- Chapter 8_Synbiotics in prostate cancer -- Chapter 9_Synbiotics in gastric cancer -- Chapter 10_Synbiotics in lung cancer -- Chapter 11_Synbiotics in small cell pancretatic cancer -- Chapter 12_Synbiotics in breast cancer -- Chapter 13_Synbiotics in hepatocellular carcinoma -- Chapter 14_Synbiotics in ovarian cancer -- Chapter 15_Regulatory issues of synbiotics in cancer. | |
| 520 | |a This book illustrates the significance of probiotics and prebiotics for the management of various types of cancers. The up-to-date chapters provide recent information about the effect of anticancer treatment approaches on gut microbiota, the correlation between ROS and synbiotics for effective cancer treatment, and the influence of synbiotics on inflammation and immune microenvironment for cancer treatment. It also describes the regulatory issues about synbiotics in the management of cancer. This book is an essential resource for scientists working in the field of cancer, pharmaceutical & clinical sciences, and cancer clinicians. This book is also very useful for undergraduate and postgraduate students of Pharmacy and Biotechnology and medical researchers, mainly working in microbiology, immunology, and cancer biology. | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Cancer. | |
| 650 | 0 | |a Cancer |x Treatment. | |
| 650 | 1 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Cancers. |
| 650 | 2 | 4 | |a Cancer Therapy. |
| 700 | 1 | |a Mishra, Neeraj. |e editor. |0 (orcid)0000-0001-9127-4469 |1 https://orcid.org/0000-0001-9127-4469 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Bhatt, Shvetank. |e editor. |0 (orcid)0000-0001-8696-3462 |1 https://orcid.org/0000-0001-8696-3462 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Paudel, Keshav Raj. |e editor. |0 (orcid)0000-0002-3591-2080 |1 https://orcid.org/0000-0002-3591-2080 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a M Hansbro, Philip. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Dua, Kamal. |e editor. |0 (orcid)0000-0002-7507-1159 |1 https://orcid.org/0000-0002-7507-1159 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9789811975493 |
| 776 | 0 | 8 | |i Printed edition: |z 9789811975516 |
| 776 | 0 | 8 | |i Printed edition: |z 9789811975523 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-19-7550-9 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||